Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 2
1979 1
1981 1
1983 1
1984 3
1985 2
1986 1
1987 3
1988 3
1989 1
1990 1
1991 3
1992 4
1993 5
1994 7
1995 3
1996 3
1997 2
1998 1
1999 9
2000 3
2001 7
2002 3
2003 6
2004 4
2005 2
2006 6
2007 7
2008 5
2009 5
2010 4
2011 9
2012 3
2013 3
2014 4
2015 5
2016 3
2017 2
2018 4
2019 3
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Results by year
Filters applied: . Clear all
Page 1
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
Jones WS, Mulder H, Wruck LM, Pencina MJ, Kripalani S, Muñoz D, Crenshaw DL, Effron MB, Re RN, Gupta K, Anderson RD, Pepine CJ, Handberg EM, Manning BR, Jain SK, Girotra S, Riley D, DeWalt DA, Whittle J, Goldberg YH, Roger VL, Hess R, Benziger CP, Farrehi P, Zhou L, Ford DE, Haynes K, VanWormer JJ, Knowlton KU, Kraschnewski JL, Polonsky TS, Fintel DJ, Ahmad FS, McClay JC, Campbell JR, Bell DS, Fonarow GC, Bradley SM, Paranjape A, Roe MT, Robertson HR, Curtis LH, Sharlow AG, Berdan LG, Hammill BG, Harris DF, Qualls LG, Marquis-Gravel G, Modrow MF, Marcus GM, Carton TW, Nauman E, Waitman LR, Kho AN, Shenkman EA, McTigue KM, Kaushal R, Masoudi FA, Antman EM, Davidson DR, Edgley K, Merritt JG, Brown LS, Zemon DN, McCormick TE 3rd, Alikhaani JD, Gregoire KC, Rothman RL, Harrington RA, Hernandez AF; ADAPTABLE Team. Jones WS, et al. Among authors: re rn. N Engl J Med. 2021 May 27;384(21):1981-1990. doi: 10.1056/NEJMoa2102137. Epub 2021 May 15. N Engl J Med. 2021. PMID: 33999548 Clinical Trial.
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.
Marquis-Gravel G, Roe MT, Robertson HR, Harrington RA, Pencina MJ, Berdan LG, Hammill BG, Faulkner M, Muñoz D, Fonarow GC, Nallamothu BK, Fintel DJ, Ford DE, Zhou L, Daugherty SE, Nauman E, Kraschnewski J, Ahmad FS, Benziger CP, Haynes K, Merritt JG, Metkus T, Kripalani S, Gupta K, Shah RC, McClay JC, Re RN, Geary C, Lampert BC, Bradley SM, Jain SK, Seifein H, Whittle J, Roger VL, Effron MB, Alvarado G, Goldberg YH, VanWormer JL, Girotra S, Farrehi P, McTigue KM, Rothman R, Hernandez AF, Jones WS. Marquis-Gravel G, et al. Among authors: re rn. JAMA Cardiol. 2020 May 1;5(5):598-607. doi: 10.1001/jamacardio.2020.0116. JAMA Cardiol. 2020. PMID: 32186653 Clinical Trial.
Thirty years of intracrinology.
Re RN. Re RN. Ochsner J. 2014 Winter;14(4):673-80. Ochsner J. 2014. PMID: 25598734 Free PMC article. Review.
Noncanonical intracrine action.
Re RN, Cook JL. Re RN, et al. J Am Soc Hypertens. 2011 Nov-Dec;5(6):435-48. doi: 10.1016/j.jash.2011.07.001. Epub 2011 Sep 3. J Am Soc Hypertens. 2011. PMID: 21890449 Review.
Obesity-related hypertension.
Re RN. Re RN. Ochsner J. 2009 Fall;9(3):133-6. Ochsner J. 2009. PMID: 21603428 Free PMC article.
Role of intracellular angiotensin II.
Re RN. Re RN. Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H766-H771. doi: 10.1152/ajpheart.00632.2017. Epub 2018 Jan 12. Am J Physiol Heart Circ Physiol. 2018. PMID: 29351452 Free article. Review.
The renin-angiotensin systems.
Re RN. Re RN. Med Clin North Am. 1987 Sep;71(5):877-95. doi: 10.1016/s0025-7125(16)30814-8. Med Clin North Am. 1987. PMID: 3306208 Review.
Studies of intracellular angiotensin II.
Re RN, Cook JL. Re RN, et al. Methods Mol Biol. 2015;1234:1-8. doi: 10.1007/978-1-4939-1755-6_1. Methods Mol Biol. 2015. PMID: 25304343 Review.
The basis of an intracrine pharmacology.
Re RN, Cook JL. Re RN, et al. J Clin Pharmacol. 2008 Mar;48(3):344-50. doi: 10.1177/0091270007312155. Epub 2008 Jan 25. J Clin Pharmacol. 2008. PMID: 18223145 Review.
144 results